Search the Newsreel

Acrivon Therapeutics (ACRV) COO’s tax sale leaves 146,349 shares

Acrivon Therapeutics (ACRV) Chief Operating Officer Eric Devroe sold 604 shares of common stock at $2.01 per share on August 18, 2026. This sale was an automatic transaction to satisfy mandatory tax withholding upon the vesting of restricted stock units. Following this transaction, Devroe …

Acrivon Therapeutics (ACRV) CLO sells 185 shares for taxes

Acrivon Therapeutics' Chief Legal Officer, Mary Miller, sold 185 shares of common stock at $2.01 per share on August 18, 2026. This transaction was an automatic sale to cover mandatory tax withholding requirements upon the vesting of restricted stock units. Following the sale, Miller …

Acrivon Therapeutics (ACRV) insider offloads 400 shares for taxes

Acrivon Therapeutics' Chief Development Officer, Erick Gamelin, sold 400 shares of common stock on August 18, 2026, at $2.01 per share. This sale was an automatic transaction to cover mandatory tax withholding upon the vesting of restricted stock units. Following this transaction, Gamelin directly …

OPEN Stock Is Losing Its Shine — But Bull Eric Jackson Thinks Q1 Earnings Will Flip The Script

John M. Leonard to sell 22,675 Intellia (NASDAQ: NTLA) shares

John M. Leonard, an officer and director at Intellia Therapeutics, Inc. (NASDAQ: NTLA), intends to sell 22,675 shares of common stock through UBS Financial Services Inc. The planned sale, with an aggregate market value of $293,641.25, is scheduled for August 20, 2026, and relates …

LAWSUIT ALERT: Investors who lost over $100,000 with Aardvark Therapeutics, Inc. (NASDAQ: AARD) between February 2025 and May 2026, should contact the Shareholders Foundation

The Shareholders Foundation announced a lawsuit alert for investors who lost over $100,000 with Aardvark Therapeutics, Inc. (NASDAQ: AARD) between February 2025 and May 2026. The lawsuit alleges that the company's IPO offering documents contained false or misleading statements regarding ARD-101's safety and prospects. …

LPSN Looks 41.0% Undervalued on GF Value™ Despite Merger Vote De

Over 100 PepsiCo employees in Columbia facing permanent layoffs, documents show

Over 100 employees at PepsiCo's Columbia, S.C., Beverages Sales facility are facing permanent layoffs, according to a WARN report. The layoffs, effective October 18, 2026, come as PepsiCo shifts warehouse logistics management, though the facility will remain operational as a distribution site. PepsiCo stated …

Class Action Lawsuit Alert: Levi & Korsinsky Reminds Freeport-McMoRan Inc. (FCX) Investors of January 12, 2026 Deadline

Levi & Korsinsky, LLP has filed a securities class action lawsuit against Freeport-McMoRan Inc. (NYSE: FCX) on behalf of investors who purchased securities between February 15, 2022, and September 24, 2025. The lawsuit alleges that Freeport-McMoRan made false statements and concealed inadequate safety measures …

PIPR Price Today: Piper Sandler Companies Stock Price, Quote & Chart | MEXC

Skipper Q1FY27 net profit rises 26.5% to ₹565M on infra surge

EPR Properties schedules Q2 FY26 earnings call for July 30

Is Janux Therapeutics (JANX) Narrowing Losses Enough To Shift Its Long-Term Risk Profile?

Simon Property Group stock steady as Scotiabank highlights strong Q2 2026 and raises price target

HighPeak Energy (HPK) After Strong Q2 Earnings Looks Undervalued But Is The Case Priced In

Nurix Therapeutics, Inc. (NRIX) Stock Price, News, Quote & History

Canadian Imperial Bank of Commerce Announces Appointment of Prasanna Gopalakrishnan to Board of Directors, Effective September 1, 2026

Canadian Imperial Bank of Commerce (CIBC) has announced the appointment of Prasanna Gopalakrishnan to its Board of Directors, effective September 1, 2026. Ms. Gopalakrishnan brings over 30 years of experience in technology, data, cyber, and artificial intelligence leadership across banking, wealth management, and global …

Cooper Companies (COO) Stock Trades At A Premium To Fair Value

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Cooper Companies stock has delivered a decline of 31.3% over the past five years, …

Keurig Dr Pepper stock draws fresh Overweight call with upside to $38

Keurig Dr Pepper (KDP) has received a new "Overweight" rating and a $38 price target from analysts, indicating a potential upside from its current trading price of around $31. This positive outlook is supported by a dividend yield near 3% and an intrinsic value …

CBL & Associates Properties Inc (CBL) EVP & COO Kathryn Reinsmid

Palvella (PVLA) Latest Quarter: EPS Comes in Below Forecast in the Available Record; Share Response: Shares Fall 6.03% for the Current Session - Consensus Forecast Report

OpenMove AI Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Barinthus (BRNS) Results Versus Estimates: Reported EPS Tops Expectations on the Day; Session Move: The Stock Records a Flat Reaction in the Available Record - Earnings Stability Report

Why Super Micro Stock Is Climbing Today

This article first appeared on GuruFocus. Super Micro Computer (NASDAQ:SMCI) shares rose 3% Thursday after the server maker completed an independent review into allegations involving the diversion of export-controlled products. The inquiry, overseen by independent directors Scott Angel and Tally Liu, examined transactions cited …

Super Micro Just Removed a Major Investor Risk

This article first appeared on GuruFocus. Super Micro Computer (NASDAQ:SMCI) shares rose more than 2% in premarket trading Thursday after the AI server maker completed an independent investigation into an alleged export-control smuggling scheme and said it found no evidence that current senior management …

Stoke Therapeutics (NASDAQ:STOK) Stock Price Down 7.9% - What's Next?

Axsome Therapeutics (AXSM) Stock Still Trades Below Fair Value On Sales

Axsome Therapeutics (AXSM) stock has seen significant gains over five years but current valuations suggest it trades below its fair value based on sales. While the company's P/S ratio of 14.7x is higher than the industry average, Simply Wall St's fair P/S ratio is …

Structure Therapeutics can't force chief financial officer’s harassment claim into arbitration

The Ninth Circuit Court of Appeals affirmed a ruling that prevents Structure Therapeutics from forcing a former CFO's sexual harassment claim into arbitration. The decision hinges on the Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act of 2021 (EFAA), which allows employees …

Simon Property Group: Raising Our Fair Value Estimate to $229; Shares Fairly Valued

Morningstar has raised its fair value estimate for Simon Property Group to $229, noting that shares are currently fairly valued. The increase comes as Simon Property Group has consistently reported strong same-store net operating income growth, achieving at least 4% annually over the past …

Qyuns Therapeutics (SEHK:2509) Stock Turns Profitable While Forecasts Cloud The Outlook

Hemab Therapeutics (NASDAQ:COAG) Trading Down 8.4% - Here's What Happened

Super Micro Computer Inc (SMCI) logs 28.0% weekly gain on heavy turnover

The server-hardware maker’s four-week move reached 64.8%, while weekly market data still show negative Relative Strength.

Rein (RNTX) Quarter in Focus: The Available Earnings Metric Delivers a Beat on the Day; Post-Report: Shares Move 0.88% Higher in the Current Update - Guidance Accuracy Score

Super Micro Jumps After Probe Clears Senior Management

This article first appeared on GuruFocus. Super Micro Computer Inc. (SMCI, Financials) climbed more than 2% after an independent probe into an alleged smuggling plot at the AI server maker was completed. Warning! GuruFocus has detected 4 Warning Signs with SMCI. Is SMCI fairly …

Why Iovance Biotherapeutics Stock Hit 52-Week High

Iovance Biotherapeutics (NASDAQ: IOVA) stock reached a 52-week high despite no new company-specific news, largely attributed to breakthrough data from Moderna and Merck & Co's individualized cancer therapy for advanced skin cancer. Iovance's own Amtagvi, an FDA-approved TIL therapy for advanced melanoma, and positive …

Does Spectrum Brands’ Q3 Loss and Intangible Impairment Reshape The Bull Case For SPB?

Spectrum Brands Holdings reported a Q3 2026 net loss of US$26.8 million, including a US$104.0 million intangible asset impairment, despite sales of US$753.3 million. The company maintained its fiscal 2026 sales growth guidance, but the impairment and weaker profitability raise concerns about earnings quality …